Tessier-Lavigne Marc
Insider CIK 1437435 · AGIO Director · JUNO Director · DNLI Director · PFE Director · REGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DNLI Denali Therapeutics Inc. | A Award deriv | 2025-06-03 | 2025-06-05 | 18,111 | — | $0 | 18,111 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2025-06-03 | 2025-06-05 | 6,037 | — | $0 | 1,886,576 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2024-05-31 | 2024-06-04 | 17,901 | — | $0 | 17,901 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2024-05-31 | 2024-06-04 | 5,967 | — | $0 | 1,880,539 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 12,649 | — | $0 | 12,649 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2023-06-01 | 2023-06-05 | 4,216 | — | $0 | 1,874,572 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2023-01-03 | 2023-01-05 | 1,929 | — | $0 | 1,929 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2023-01-03 | 2023-01-05 | 1,929 | — | $0 | 1,929 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2023-01-03 | 2023-01-05 | 165 | — | $0 | 2,434 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2023-01-03 | 2023-01-05 | 165 | — | $0 | 2,434 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-11-23 | 2022-11-28 | 20,000 | $30.48 | $609.6K | 1,870,356 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-11-02 | 2022-11-03 | 11,252 | $30.33 | $341.3K | 1,890,356 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-11-01 | 2022-11-03 | 8,748 | $30.20 | $264.2K | 1,901,608 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-10-03 | 2022-10-03 | 3,612 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-10-03 | 2022-10-03 | 3,612 | $718.00 | $2.59M | 2,269 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-10-03 | 2022-10-03 | 3,612 | $413.33 | $1.49M | 5,881 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-09-30 | 2022-10-03 | 3,428 | — | $0 | 3,612 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-30 | 2022-10-03 | 3,428 | $698.00 | $2.39M | 2,269 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-09-30 | 2022-10-03 | 3,428 | $413.33 | $1.42M | 5,697 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-09-29 | 2022-10-03 | 3,798 | — | $0 | 7,040 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-29 | 2022-10-03 | 1,009 | $689.56 | $695.8K | 4,084 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-29 | 2022-10-03 | 637 | $688.71 | $438.7K | 5,093 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-29 | 2022-10-03 | 692 | $690.65 | $477.9K | 3,392 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-29 | 2022-10-03 | 554 | $691.59 | $383.1K | 2,838 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-29 | 2022-10-03 | 85 | $696.13 | $59.2K | 2,753 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-29 | 2022-10-03 | 160 | $697.29 | $111.6K | 2,593 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-29 | 2022-10-03 | 208 | $698.44 | $145.3K | 2,385 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-29 | 2022-10-03 | 321 | $687.90 | $220.8K | 5,730 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-29 | 2022-10-03 | 16 | $686.89 | $11.0K | 6,051 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-09-29 | 2022-10-03 | 3,798 | $413.33 | $1.57M | 6,067 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-29 | 2022-10-03 | 20 | $704.83 | $14.1K | 2,269 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-29 | 2022-10-03 | 16 | $702.36 | $11.2K | 2,289 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-29 | 2022-10-03 | 80 | $699.82 | $56.0K | 2,305 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-09-28 | 2022-09-30 | 15,577 | $30.74 | $478.8K | 1,914,779 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-09-28 | 2022-09-30 | 4,423 | $31.08 | $137.5K | 1,910,356 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-08-23 | 2022-08-25 | 100 | $32.43 | $3.2K | 1,930,356 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-08-23 | 2022-08-25 | 19,900 | $31.61 | $629.0K | 1,930,456 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-07-25 | 2022-07-27 | 200 | $36.15 | $7.2K | 1,950,356 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-07-25 | 2022-07-27 | 19,800 | $35.60 | $704.9K | 1,950,556 | SEC↗ |
| DNLI Denali Therapeutics Inc. | D To issuer | 2022-06-24 | 2022-06-27 | 39,984 | $30.53 | $1.22M | 1,977,122 | SEC↗ |
| DNLI Denali Therapeutics Inc. | D To issuer | 2022-06-24 | 2022-06-27 | 6,766 | $31.08 | $210.3K | 1,970,356 | SEC↗ |
| DNLI Denali Therapeutics Inc. | D To issuer | 2022-06-23 | 2022-06-27 | 13,250 | $31.10 | $412.1K | 2,017,106 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 17,959 | — | $0 | 17,959 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2022-06-02 | 2022-06-06 | 5,986 | — | $0 | 2,030,356 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-03-23 | 2022-06-28 | 8,402 | $33.40 | $280.6K | 2,035,968 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-03-23 | 2022-06-28 | 11,598 | $34.14 | $396.0K | 2,024,370 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-03-23 | 2022-03-25 | 11,598 | $34.14 | $396.0K | 2,024,370 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2022-03-23 | 2022-03-25 | 8,402 | $33.40 | $280.6K | 2,035,968 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-03-21 | 2022-03-23 | 7,439 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-03-21 | 2022-03-23 | 7,439 | $690.00 | $5.13M | 2,269 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-03-21 | 2022-03-23 | 7,439 | $380.95 | $2.83M | 9,708 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-03-17 | 2022-03-18 | 7,830 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-03-17 | 2022-03-18 | 7,830 | $376.69 | $2.95M | 10,099 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-03-17 | 2022-03-18 | 7,830 | $680.00 | $5.32M | 2,269 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-03-16 | 2022-03-18 | 4,361 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-03-16 | 2022-03-18 | 4,361 | $675.00 | $2.94M | 2,269 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-03-16 | 2022-03-18 | 4,361 | $374.12 | $1.63M | 6,630 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2022-01-03 | 2022-01-05 | 2,707 | — | $0 | 2,707 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2022-01-03 | 2022-01-05 | 191 | — | $0 | 2,269 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-12-30 | 2021-12-30 | 3,377 | $45.59 | $154.0K | 78,848 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-12-30 | 2021-12-30 | 3,343 | $45.13 | $150.9K | 82,225 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-12-30 | 2021-12-30 | 800 | $45.72 | $36.6K | 78,848 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-12-30 | 2021-12-30 | 5,625 | $45.31 | $254.9K | 80,073 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-12-30 | 2021-12-30 | 900 | $45.71 | $41.1K | 79,173 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-12-30 | 2021-12-30 | 6,002 | $45.31 | $272.0K | 79,648 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-12-29 | 2021-12-30 | 10,700 | $43.87 | $469.4K | 85,698 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-12-29 | 2021-12-30 | 10,704 | $43.88 | $469.7K | 85,650 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-12-29 | 2021-12-30 | 10,700 | $43.88 | $469.5K | 85,568 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-12-28 | 2021-12-30 | 3,602 | $44.38 | $159.9K | 96,398 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-12-28 | 2021-12-30 | 3,732 | $44.37 | $165.6K | 96,268 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-12-28 | 2021-12-30 | 3,646 | $44.37 | $161.8K | 96,354 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-12-09 | 2021-12-10 | 3,784 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-12-09 | 2021-12-10 | 3,784 | $371.40 | $1.41M | 5,862 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-12-09 | 2021-12-10 | 3,784 | $665.00 | $2.52M | 2,078 | SEC↗ |
| DNLI Denali Therapeutics Inc. | G Gift | 2021-10-04 | 2021-12-30 | 100,000 | — | $0 | 100,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | G Gift | 2021-10-04 | 2021-12-30 | 100,000 | — | $0 | 100,000 | SEC↗ |
| DNLI Denali Therapeutics Inc. | G Gift | 2021-10-04 | 2021-12-30 | 300,000 | — | $0 | 2,244,370 | SEC↗ |
| DNLI Denali Therapeutics Inc. | G Gift | 2021-10-04 | 2021-12-30 | 100,000 | — | $0 | 100,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-09-13 | 2021-09-15 | 4,250 | — | $0 | 8,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-09-13 | 2021-09-15 | 4,250 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-09-13 | 2021-09-15 | 4,250 | — | $0 | 4,250 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 1,645 | $642.54 | $1.06M | 6,260 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 816 | $636.64 | $519.5K | 14,012 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 816 | $637.71 | $520.4K | 13,196 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 2,098 | $638.46 | $1.34M | 11,098 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 1,260 | $639.45 | $805.7K | 9,838 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 981 | $640.61 | $628.4K | 8,857 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 952 | $641.56 | $610.8K | 7,905 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-09-13 | 2021-09-15 | 4,250 | $273.67 | $1.16M | 14,828 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-09-13 | 2021-09-15 | 4,250 | $273.67 | $1.16M | 10,578 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-09-13 | 2021-09-15 | 4,250 | $273.67 | $1.16M | 6,328 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 139 | $652.26 | $90.7K | 2,078 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 249 | $651.54 | $162.2K | 2,217 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 56 | $650.33 | $36.4K | 2,466 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 124 | $649.35 | $80.5K | 2,522 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 381 | $648.25 | $247.0K | 2,646 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 425 | $647.39 | $275.1K | 3,027 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 354 | $646.24 | $228.8K | 3,452 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 61 | $645.21 | $39.4K | 3,806 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 844 | $644.52 | $544.0K | 3,867 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 1,549 | $643.33 | $996.5K | 4,711 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2021-06-07 | 2021-06-08 | 27,245 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2021-06-07 | 2021-06-08 | 39,303 | — | $0 | 7,862 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise deriv | 2021-06-07 | 2021-06-08 | 27,830 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-06-07 | 2021-06-08 | 700 | $71.06 | $49.7K | 2,544,370 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2021-06-07 | 2021-06-08 | 39,303 | $18.00 | $707.5K | 2,583,673 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2021-06-07 | 2021-06-08 | 27,830 | $18.92 | $526.5K | 2,611,503 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-06-07 | 2021-06-08 | 93,678 | $70.35 | $6.59M | 2,545,070 | SEC↗ |
| DNLI Denali Therapeutics Inc. | M Exercise | 2021-06-07 | 2021-06-08 | 27,245 | $19.50 | $531.3K | 2,638,748 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2021-06-02 | 2021-06-04 | 6,222 | — | $0 | 6,222 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award | 2021-06-02 | 2021-06-04 | 2,074 | — | $0 | 2,544,370 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-05-24 | 2021-05-24 | 8,806 | $60.03 | $528.6K | 2,542,296 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-05-21 | 2021-05-24 | 37,957 | $60.13 | $2.28M | 2,551,102 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-05-03 | 2021-05-05 | 3,139 | $60.08 | $188.6K | 2,589,157 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-05-03 | 2021-05-05 | 98 | $61.20 | $6.0K | 2,589,059 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-04-01 | 2021-04-05 | 14,223 | $55.61 | $790.9K | 2,628,073 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-04-01 | 2021-04-05 | 29,593 | $56.91 | $1.68M | 2,598,480 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-04-01 | 2021-04-05 | 6,184 | $57.60 | $356.2K | 2,592,296 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-01 | 2021-03-03 | 6,011 | $68.50 | $411.8K | 2,646,809 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-01 | 2021-03-03 | 1,031 | $71.35 | $73.6K | 2,642,296 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-01 | 2021-03-03 | 18,770 | $64.36 | $1.21M | 2,723,526 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-01 | 2021-03-03 | 37,445 | $65.63 | $2.46M | 2,686,081 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-01 | 2021-03-03 | 18,316 | $66.55 | $1.22M | 2,667,765 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-01 | 2021-03-03 | 14,945 | $67.57 | $1.01M | 2,652,820 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2021-03-01 | 2021-03-03 | 3,482 | $69.59 | $242.3K | 2,643,327 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2021-01-04 | 2021-01-05 | 3,613 | — | $0 | 3,613 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2021-01-04 | 2021-01-05 | 248 | — | $0 | 2,078 | SEC↗ |
| DNLI Denali Therapeutics Inc. | S Sale | 2020-06-16 | 2020-06-18 | 400,000 | $26.10 | $10.44M | 2,739,043 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 15,183 | — | $0 | 15,183 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2020-06-03 | 2020-06-05 | 3,253 | — | $0 | 3,253 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-05-06 | 2020-05-08 | 15,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-06 | 2020-05-08 | 900 | $565.35 | $508.8K | 1,930 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-05-06 | 2020-05-08 | 15,000 | $177.82 | $2.67M | 16,830 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-06 | 2020-05-08 | 1,025 | $562.65 | $576.7K | 15,805 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-06 | 2020-05-08 | 6,375 | $563.45 | $3.59M | 9,430 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-06 | 2020-05-08 | 100 | $566.01 | $56.6K | 1,830 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-06 | 2020-05-08 | 6,600 | $564.45 | $3.73M | 2,830 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-02-13 | 2020-02-14 | 5,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-02-13 | 2020-02-14 | 9,279 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-02-13 | 2020-02-14 | 5,000 | $57.11 | $285.6K | 6,830 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-02-13 | 2020-02-14 | 5,000 | $400.03 | $2.00M | 1,830 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-02-13 | 2020-02-14 | 9,279 | $50.91 | $472.4K | 11,109 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-02-13 | 2020-02-14 | 7,842 | $400.16 | $3.14M | 1,830 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-02-13 | 2020-02-14 | 800 | $399.41 | $319.5K | 9,672 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-02-13 | 2020-02-14 | 637 | $398.71 | $254.0K | 10,472 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2020-01-02 | 2020-01-06 | 4,361 | — | $0 | 4,361 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2020-01-02 | 2020-01-06 | 320 | — | $0 | 1,830 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2019-05-30 | 2019-05-31 | 27,245 | — | $0 | 27,245 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2019-01-02 | 2019-01-04 | 3,784 | — | $0 | 3,784 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award | 2019-01-02 | 2019-01-04 | 323 | — | $0 | 1,510 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2018-06-13 | 2018-06-15 | 27,830 | — | $0 | 27,830 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2018-01-02 | 2018-01-03 | 7,439 | — | $0 | 7,439 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion deriv | 2017-12-12 | 2017-12-12 | 25,000 | — | $0 | 0 | SEC↗ |
| DNLI Denali Therapeutics Inc. | C Conversion | 2017-12-12 | 2017-12-12 | 25,000 | — | $0 | 3,139,043 | SEC↗ |
| DNLI Denali Therapeutics Inc. | A Award deriv | 2017-12-07 | 2017-12-08 | 47,165 | — | $0 | 47,165 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2017-01-03 | 2017-01-05 | 7,830 | — | $0 | 7,830 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2016-06-21 | 2016-06-23 | 8,500 | — | $0 | 48,875 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2016-06-17 | 2016-06-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2016-01-04 | 2016-01-06 | 9,212 | — | $0 | 9,212 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-08-05 | 2015-08-05 | 5,000 | — | $0 | 5,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-08-05 | 2015-08-05 | 500 | $595.44 | $297.7K | 1,187 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-08-05 | 2015-08-05 | 5,000 | $57.11 | $285.6K | 6,187 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-08-05 | 2015-08-05 | 1,500 | $584.07 | $876.1K | 4,687 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-08-05 | 2015-08-05 | 1,000 | $590.17 | $590.2K | 3,687 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-08-05 | 2015-08-05 | 2,000 | $593.64 | $1.19M | 1,687 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2015-06-23 | 2015-06-25 | 11,262 | — | $0 | 40,375 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | A Award deriv | 2015-06-12 | 2015-06-16 | 12,000 | — | $0 | 12,000 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2015-04-23 | 2015-04-24 | 4,596 | $35.36 | $162.5K | 29,100 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-02-26 | 2015-02-27 | 3,000 | — | $0 | 9,279 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-02-26 | 2015-02-27 | 300 | $424.44 | $127.3K | 1,187 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-02-26 | 2015-02-27 | 1,100 | $423.64 | $466.0K | 1,487 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-02-26 | 2015-02-27 | 1,600 | $420.33 | $672.5K | 2,587 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-02-26 | 2015-02-27 | 3,000 | $50.91 | $152.7K | 4,187 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2015-01-02 | 2015-01-05 | 10,838 | — | $0 | 10,838 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion deriv | 2014-12-23 | 2014-12-23 | 175,000 | — | $0 | 0 | SEC↗ |
| JUNO Juno Therapeutics, Inc. | C Conversion | 2014-12-23 | 2014-12-23 | 175,000 | — | $0 | 250,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2014-08-27 | 2014-08-27 | 3,000 | — | $0 | 12,279 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-08-27 | 2014-08-27 | 3,000 | $352.20 | $1.06M | 1,187 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2014-08-27 | 2014-08-27 | 3,000 | $50.91 | $152.7K | 4,187 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2014-08-26 | 2014-08-27 | 1,387 | — | $0 | 15,279 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2014-08-26 | 2014-08-27 | 200 | $351.62 | $70.3K | 1,187 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2014-08-26 | 2014-08-27 | 1,387 | $50.91 | $70.6K | 1,387 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2014-05-30 | 2014-06-05 | 14,000 | — | $0 | 29,113 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2014-04-24 | 2014-04-28 | 5,291 | $30.71 | $162.5K | 23,671 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2014-01-02 | 2014-01-06 | 12,750 | — | $0 | 12,750 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2013-12-04 | 2013-12-06 | 10,750 | — | $0 | 15,113 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | P Buy | 2013-07-24 | 2014-04-03 | 55,555 | $18.00 | $1000.0K | 101,009 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-05-06 | 2013-05-08 | 8,334 | — | $0 | 16,666 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-05-06 | 2013-05-08 | 300 | — | $0 | 10,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-05-06 | 2013-05-08 | 500 | — | $0 | 10,300 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-05-06 | 2013-05-08 | 1,700 | — | $0 | 10,800 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-05-06 | 2013-05-08 | 1,700 | — | $0 | 12,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-05-06 | 2013-05-08 | 800 | — | $0 | 14,200 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-06 | 2013-05-08 | 500 | $263.50 | $131.8K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-05-06 | 2013-05-08 | 1,700 | $57.11 | $97.1K | 1,700 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-06 | 2013-05-08 | 1,700 | $261.53 | $444.6K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-05-06 | 2013-05-08 | 1,700 | $57.11 | $97.1K | 1,700 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-06 | 2013-05-08 | 1,700 | $262.49 | $446.2K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-05-06 | 2013-05-08 | 500 | $57.11 | $28.6K | 500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-06 | 2013-05-08 | 800 | $260.75 | $208.6K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-05-06 | 2013-05-08 | 300 | $57.11 | $17.1K | 300 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-06 | 2013-05-08 | 300 | $264.17 | $79.3K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-05-06 | 2013-05-08 | 8,334 | $50.91 | $424.3K | 8,334 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-06 | 2013-05-08 | 8,334 | $260.20 | $2.17M | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-05-06 | 2013-05-08 | 800 | $57.11 | $45.7K | 800 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-04-25 | 2013-04-26 | 4,544 | $30.26 | $137.5K | 17,794 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2013-01-02 | 2013-01-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2012-04-26 | 2012-04-27 | 5,963 | $23.06 | $137.5K | 12,776 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2012-01-03 | 2012-01-04 | 15,000 | — | $0 | 15,000 | SEC↗ |